Papers
1
Total Citations
16
H-Index
1
About
Dr. Changling Li is a pioneering urologic surgeon whose work is reshaping the diagnostic pathway for prostate cancer. His primary research focuses on integrating advanced imaging and minimally invasive techniques to challenge traditional diagnostic protocols. Dr. Li’s most notable contribution, detailed in his 2019 paper "Feasibility of prostatectomy without prostate biopsy in the era of new imaging technology and minimally invasive techniques" (16 citations), proposes a paradigm shift: bypassing the conventional, often inaccurate prostate biopsy by leveraging state-of-the-art imaging to directly proceed with surgery. This work directly addresses the limitations of ultrasound-guided biopsies, which can miss significant cancers, and advocates for a more precise, patient-centered approach. By questioning long-standing clinical dogma, Dr. Li’s research has sparked important discussions on reducing unnecessary procedures and improving cancer detection accuracy. Though early in its citation impact, this provocative study signals his role as a forward-thinking innovator, pushing the boundaries of urologic oncology toward a future where diagnosis and treatment are more seamlessly integrated.
Research Focus
Key Achievements
Top Papers
- 1